December 17, 2018 / 6:09 AM / 6 months ago

BRIEF-Roche Holding Says EMA Grants Prime Designation For Risdiplam For Treatment Of SMA

Dec 17 (Reuters) - Roche Holding AG:

* SAYS PRIME DESIGNATION GRANTED BY EUROPEAN MEDICINES AGENCY FOR ROCHE’S RISDIPLAM FOR TREATMENT OF SPINAL MUSCULAR ATROPHY (SMA) Source text: here Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below